Ablative material for use with tissue treatment device

Information

  • Patent Grant
  • 7951149
  • Patent Number
    7,951,149
  • Date Filed
    Tuesday, October 17, 2006
    18 years ago
  • Date Issued
    Tuesday, May 31, 2011
    13 years ago
Abstract
An electrosurgical instrument for treating tissue includes a housing having at least one tissue treating member attached thereto. The tissue treating member includes an electrically conductive tissue contacting surface connected to a source of electrosurgical energy such that the tissue contacting surface is capable of conducting electrosurgical energy to tissue. An energy conductive, ablative material is disposed on the electrically conductive tissue contacting surface and is configured to at least partially deplete during electrosurgical activation to reduce tissue adhesion.
Description
BACKGROUND

The present disclosure relates to an electrode assembly for use with electrosurgical instruments and, more particularly, the present disclosure relates to an electrode assembly including an electrically conductive tissue engaging surface having an ablative material disposed thereon to reduce tissue adhesion during activation.


TECHNICAL FIELD

Open or endoscopic electrosurgical forceps utilize both mechanical clamping action and electrical energy to effect hemostasis. The electrode of each opposing jaw members is charged to a different electric potential such that when the jaw members grasp tissue, electrical energy can be selectively transferred through the tissue. A surgeon can either seal, cauterize, ablate, coagulate/desiccate, cut, dissect and/or simply reduce or slow bleeding, by controlling the intensity, frequency and duration of the electrosurgical energy applied between the electrodes and through the tissue. For the purposes herein, “coagulation” is defined as a process of desiccating tissue wherein the tissue cells are ruptured and dried. “Vessel sealing” is defined as the process of liquefying the collagen in the tissue so that it reforms into a fused mass with significantly-reduced demarcation between the opposing tissue structures (opposing walls of the lumen). Coagulation of small vessels is usually sufficient to permanently close them. Larger vessels need to be sealed to assure permanent closure.


To effectively seal tissue or vessels, especially thick tissue and large vessels, two predominant mechanical parameters must be accurately controlled: 1) the pressure applied to the vessel, which is ideally between about 3 kg/cm2 to about 16 kg/cm2; and 2) the gap distance between the conductive tissue contacting surfaces (between about 0.001 and about 0.006 inches).


During any electrosurgical procedure involving cauterization, coagulation, sealing, ablation, dissection and/or cutting there is a possibility that tissue will adhere or stick to the electrically conductive surfaces. Previously developed devices have been successful in reducing tissue adhesion by manufacturing or coating the electrically conductive surfaces with non-stick materials, such as nickel-chrome, and nitride coatings, such as chromium nitride, MedCoat 2000, Inconel 600 and tin-nickel. Nitride coatings (e.g., TiN, ZrN, TiAlN, and CrN) have been particularly successful in producing non-stick properties. For example, CrN has been found to be particularly useful for non-stick purposes due to its overall surface properties and optimal performance. Other classes of materials have also been found to reduce overall sticking. For example, high nickel/chrome alloys with a Ni/Cr ratio of approximately 5:1 have been found to significantly reduce sticking in bipolar instrumentation. One particularly useful non-stick material in this class is Inconel 600. Bipolar instrumentation having sealing surfaces and made from or coated with Ni200, Ni201 (˜100% Ni) also showed improved non-stick performance over typical bipolar stainless steel electrodes. As can be appreciated, these properties are desirable for electrosurgical instrumentation that are naturally exposed to high temperatures, high RF energy and organic matter.


SUMMARY

The present disclosure relates to an electrosurgical instrument for treating tissue and includes a housing having at least one tissue treating member attached thereto. The tissue treating member includes an electrically conductive tissue contacting surface connected to a source of electrosurgical energy such that the tissue contacting surface is capable of conducting electrosurgical energy to tissue. An energy conductive, ablative material is disposed on the electrically conductive tissue contacting surface and is configured to at least partially deplete during electrosurgical activation to reduce tissue adhesion. The instrument may be any one of a variety of instruments including bipolar instruments, monopolar instrument, ablation instruments, thermal treatment instruments, ultrasonic instruments, microwave instruments and radiofrequency instruments. The energy conductive, ablative material may include one or more materials selected from a group of materials consisting of: fiberglass material impregnated with phenolic resin and silica powder; combinations of phenolic resin, polyamide and silica powder; silicone elastomer, rayon-based carbon material, ceramic-forming polymer, etc. The energy conductive, ablative material may also be sterilizeable for a pre-determined number of sterilization cycles.


The present disclosure also relates to an electrode assembly for use with an electrosurgical instrument which includes a pair of opposing first and second jaw members being movable relative to one another from a first position wherein the jaw members are disposed in spaced relation relative to one another to a second position wherein the jaw members cooperate to grasp tissue therebetween. Each jaw member includes an electrically conductive tissue contacting surface which is connected to a source of electrosurgical energy such that the tissue contacting surfaces are capable of conducting electrosurgical energy through the tissue held therebetween. At least one of the tissue contacting surfaces includes an energy conductive, ablative material disposed thereon which is configured or formulated to at least partially deplete during electrosurgical activation to reduce tissue adhesion.


In one embodiment according to the present disclosure, the energy conductive, ablative material is applied to the at least one electrically conductive surface prior to or during electrosurgical application in the form of a gel or a liquid material. The ablative material may also be formed on the conductive surfaces in a solid form during a manufacturing step. In another embodiment, a sensor may also be included which monitors the depletion rate of the energy conductive, ablative material and relays information relating to the depletion rate back to the electrosurgical energy source. The electrosurgical energy source may include an audible and/or visual indicator which warns a user when the sensor relays information relating to the depletion rate which falls within a predefined threshold.


In yet another embodiment, the electrosurgical energy source measures the changes in electrical properties of the electrically conductive surface(s) corresponding to the amount of energy conductive, ablative material loss over time and modifies the electrosurgical energy delivery based thereon to maintain proper energy delivery during electrosurgery.


The present disclosure also relates to an electrode assembly for use with an instrument for sealing tissue which includes a pair of opposing first and second jaw members movable relative to one another from a first position wherein the jaw members are disposed in spaced relation relative to one another to a second position wherein the jaw members cooperate to grasp tissue therebetween. Each jaw member includes an electrically conductive tissue contacting surface connected to a source of electrosurgical energy such that the tissue contacting surfaces are capable of conducting electrosurgical energy through the tissue held therebetween to effect a seal. At least one of the tissue contacting surfaces of one of the jaw members including an energy conductive, ablative material disposed thereon which is configured to at least partially burn off during electrosurgical activation to reduce tissue adhesion. The source of electrosurgical energy includes an algorithm which monitors at least one electrical property of the electrically conductive surface(s) and continuously modifies energy delivery based thereon.


The present disclosure also relates to a method for sealing tissue and includes the initial step of providing an electrode assembly including: a pair of opposing first and second jaw members, each jaw member including an electrically conductive tissue contacting surface adapted to connect to a source of electrosurgical energy such that the tissue contacting surfaces are capable of conducting electrosurgical energy through tissue held therebetween to effect a tissue seal; and at least one of the tissue contacting surfaces of one of the jaw members including an energy conductive, ablative material disposed thereon, the energy conductive, ablative material being configured to at least partially burn off during electrosurgical activation to reduce tissue adhesion.


The method also includes the steps of: moving the jaw member relative to one another to grasp tissue therebetween; applying electrosurgical energy to the tissue contacting surfaces to conduct electrosurgical energy through tissue held therebetween; and monitoring at least one electrical property of the at least one electrically conductive surface and continuously modifying energy delivery based thereon.


In one embodiment, the electrode assembly further includes a sensor and the method further includes the steps of: monitoring a depletion rate of the energy conductive, ablative material with the sensor; and relaying information relating to the depletion rate back to the source of electrosurgical energy.





BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments of the present disclosure are described herein with reference to the drawings wherein:



FIG. 1A is a right, perspective view of an endoscopic bipolar forceps showing a housing, a shaft and an electrode assembly according to the present disclosure;



FIG. 1B is a right, perspective view of an open bipolar forceps having an electrode assembly according to the present disclosure;



FIG. 2 is an enlarged view of the electrode assembly of FIG. 1B showing tissue contacting surfaces of the electrode assembly; and



FIG. 3 is an enlarged front view taken along line 3-3 of FIG. 2 showing schematic electrical connections to the tissue contacting surfaces of the jaw members.





DETAILED DESCRIPTION

Referring now to FIGS. 1A and 1B, an endoscopic bipolar forceps 10 is shown for use with various surgical procedures. Forceps 10 generally includes a housing 20, a handle assembly 30, a rotating assembly 80, a trigger assembly 70 and an electrode assembly 110 that mutually cooperate to grasp, seal and divide tubular vessels and vascular tissue. Although FIG. 1A depicts a bipolar forceps 10 for use in connection with endoscopic surgical procedures and FIG. 1B depicts an open forceps 200 for use in connection with traditional open surgical procedures, other suitable endoscopic or open electrosurgical instruments are contemplated, that include electrodes or electrically conductive surfaces that are applicable to the presently described disclosure, e.g., electrosurgical knives, electrosurgical pencils, electrosurgical scissors, ablation instruments, thermal treatment instruments, ultrasonic instruments, microwave instruments and radiofrequency instruments.


For the purposes herein, any of the aforementioned instruments may be utilized with the present disclosure. Moreover, either an endoscopic instrument or an open instrument may be utilized with the presently disclosed electrosurgical instrument and electrode assembly described herein. Obviously, and with particular respect to an electrosurgical forceps, different electrical and mechanical connections and considerations apply to each particular type of instrument; however, the novel aspects with respect to the electrosurgical instrument and electrode assembly and its operating characteristics remain generally consistent with respect to both the open or endoscopic designs.


More particularly, forceps 10 includes a shaft 12 that has a distal end 14 dimensioned to mechanically engage the electrode assembly 110 and a proximal end 16 that mechanically engages the housing 20. The shaft 12 may be bifurcated at the distal end 14 thereof to receive the electrode assembly 110. The proximal end 16 of shaft 12 mechanically engages the rotating assembly 80 to facilitate rotation of the electrode assembly 110. In the drawings and in the descriptions that follow, the term “proximal”, as is traditional, will refer to the end of the forceps 10 that is closer to the user, while the term “distal” will refer to the end that is further from the user.


As best seen in FIG. 1A, forceps 10 also includes an electrical interface or plug 301 that connects the forceps 10 to a source of electrosurgical energy, e.g., an electrosurgical generator 500 (FIG. 3). Plug 301 includes a pair of prong members 302a and 302b that are dimensioned to mechanically and electrically connect the forceps 10 to the electrosurgical generator 500 (FIG. 3). An electrical cable 310 extends from the plug 301 to a sleeve 99 that securely connects the cable 310 to the forceps 10. Cable 310 is internally divided within the housing 20 to transmit electrosurgical energy through various electrical feed paths to the electrode assembly 110.


Handle assembly 30 includes a fixed handle 50 and a movable handle 40. Fixed handle 50 is integrally associated with housing 20 and handle 40 is movable relative to fixed handle 50 to actuate a pair of opposing jaw members 280 and 282 of the electrode assembly 110 as explained in more detail below. Movable handle 40 and trigger assembly 70 are preferably of unitary construction and are operatively connected to the housing 20 and the fixed handle 50 during the assembly process.


As mentioned above, electrode assembly 110 is attached to the distal end 14 of shaft 12 and includes a pair of opposing jaw members 280 and 282. Movable handle 40 of handle assembly 30 imparts movement of the jaw members 280 and 282 from an open position wherein the jaw members 280 and 282 are disposed in spaced relation relative to one another, to a clamping or closed position wherein the jaw members 280 and 282 cooperate to grasp tissue therebetween.


Forceps 10 may be designed such that it is fully or partially disposable depending upon a particular purpose or to achieve a particular result. For example, electrode assembly 110 may be selectively and releasably engageable with the distal end 14 of the shaft 12 and/or the proximal end 16 of shaft 12 may be selectively and releasably engageable with the housing 20 and the handle assembly 30. In either of these two instances, the forceps 10 would be considered “partially disposable” or “reposable”, i.e., a new or different electrode assembly 110 (or electrode assembly 110 and shaft 12) selectively replaces the old electrode assembly 110 as needed.


Referring now to FIG. 1B, an open forceps 200 is shown which includes a pair of elongated shaft portions 212a each having a proximal end 216a and 216b, respectively, and a distal end 214a and 214b, respectively. The forceps 200 includes electrode assembly 210 that attaches to distal ends 214a and 214b of shafts 212a and 212b, respectively. Electrode assembly 210 includes opposing jaw members 280 and 282 which are pivotably connected about a pivot pin 219.


Each shaft 212a and 212b includes a handle 217a and 217b disposed at the proximal end 216a and 216b thereof that each defines a finger hole 218a and 218b, respectively, therethrough for receiving a finger of the user. As can be appreciated, finger holes 218a and 218b facilitate movement of the shafts 212a and 212b relative to one another, which, in turn, pivot the jaw members 280 and 282 from an open position wherein the jaw members 280 and 282 are disposed in spaced relation relative to one another to a clamping or closed position wherein the jaw members 280 and 282 cooperate to grasp tissue therebetween. A ratchet 230 may be included for selectively locking the jaw members 280 and 282 relative to one another at various positions during pivoting.


Each position associated with the cooperating ratchet interfaces 230 holds a specific, i.e., constant, strain energy in the shaft members 212a and 212b, which, in turn, transmits a specific closing force to the jaw members 280 and 282. The ratchet 230 may include graduations or other visual markings which enable the user to easily and quickly ascertain and control the amount of closure force desired between the jaw members 280 and 282.


One of the shafts, e.g., 212b, includes a proximal shaft connector/flange 221 that is designed to connect the forceps 200 to a source of electrosurgical energy, such as an electrosurgical generator 342. More particularly, flange 221 mechanically secures electrosurgical cable 310 to the forceps 200 such that the user may selectively apply electrosurgical energy as needed. The proximal end of the cable 310 includes a similar plug 301 as described above with respect to FIG. 1A. The interior of cable 310 houses a pair of leads that conduct different electrical potentials from the electrosurgical generator 500 (FIG. 3) to the jaw members 280 and 282 as explained below with respect to FIG. 2.


The jaw members 280 and 282 are generally symmetrical and include similar component features that cooperate to permit facile rotation about pivot 219 to effect the grasping and sealing of tissue. Each jaw member 280 and 282 includes an electrically conductive tissue contacting surface 284 and 286, respectively, which cooperate to engage the tissue during sealing and cutting. One of the jaw members may include a cutting element 295 disposed therein, that is explained in detail below.


As best shown in FIGS. 1B and 2, the various electrical connections of the electrode assembly 210 are preferably configured to provide electrical continuity to the tissue contacting surfaces 284 and 286. More particularly, two connector pins 307 and 308 are located at the proximal end of the electrode assembly 210. Connections 307 and 308 are preferably mechanically and electrically interfaced with corresponding electrical connections (not shown) disposed within shafts 212a and 212b, respectively. As can be appreciated, the electrical connectors 307 and 308 may be permanently soldered to the shafts 212a and 212b during the assembly process of a disposable instrument or, alternatively, selectively removable for use with a reposable instrument.


Connector 307 is internally connected to lead 298 disposed within the electrode assembly 210 to provide electrical continuity to tissue contacting surface 286 of jaw member 282. Likewise, connector 308 is internally connected to lead 297 and provides electrical continuity to tissue contacting surface 284 of jaw member 280. The electrode assembly 210 may also be configured to include a knife 295, which is selectively translatable within a corresponding jaw channel 294 disposed in jaw member 282 (and/or jaw member 280). In this instance, connector 308 may also include a second electrical interface 309 that provides electrical continuity to a cutting element through electrode assembly 210. Interfaces 308 and 309 are preferably dielectrically insulated from one another to allow selective and independent activation of either the tissue contacting surface 284 or the cutting element.


Alternatively, the electrode assembly 210 may include a single connector, e.g., 308, which includes an internal switch to allow selective and independent activation of the tissue contacting surface 284 and the cutting element. Preferably, leads 297, 298 and 299 (and/or conductive pathways) do not encumber the movement of the jaw members 280 and 282 relative to one another during the manipulation and grasping of tissue. Likewise, the movement of the jaw members 280 and 282 do not unnecessarily strain the lead connections 297, 298 and 299.


As best seen in FIG. 2 jaw members 280 and 282 both include conductive tissue contacting surfaces 284 and 286, respectively, disposed along substantially the entire longitudinal length thereof (i.e., extending substantially from the proximal to distal end of each respective jaw member 280 and 284). The tissue contacting surfaces are disposed in general vertical opposition relative to one another to facilitate grasping of tissue and tissue treatment. Tissue contacting surfaces 284 and 286 may be attached to the jaw member 280 and 284 by stamping, by overmolding, by casting, by overmolding a casting, by coating a casting, by overmolding a stamped electrically conductive sealing plate and/or by overmolding a metal injection molded seal plate. All of these manufacturing techniques can be employed to produce jaw member 280 and 284 having electrically conductive tissue contacting surfaces 284 and 286 disposed thereon for contacting and grasping tissue.


The electrically conductive sealing surfaces 284 and 286 may also each include a pinch trim 291 and 293 that facilitates secure engagement of the electrically conductive surfaces 284 and 286 to the jaw members 280 and 282 and also simplifies the overall manufacturing process. The jaw members 280 and 282 are configured to include an insulator or insulative material 290 and 292, respectively, disposed on the outer periphery and substantially along the entire longitudinal length thereof. Each insulative material 290 and 292 is configured to house respective tissue contacting surfaces 284 and 286. Each electrically conductive tissue sealing surface 284 and 286 may also include an outer peripheral edge that has a radius and the respective insulative material 290 and 292 of each jaw member 280 and 282 meets the electrically conductive sealing surface 284 and 286 along an adjoining edge, which is generally tangential to the radius and/or meets along the radius.


One or both of the insulators 290 and 292 may be made from a ceramic material due to its hardness and inherent ability to withstand high temperature fluctuations. Alternatively, one or both of the insulators 290 and 292 may be made from a material having a high Comparative Tracking Index (CTI) having a value in the range of about 300 to about 600 volts. Examples of high CTI materials include nylons and syndiotactic polystryrenes, such as QUESTRA® manufactured by DOW Chemical. Other materials may also be utilized either alone or in combination, e.g., Nylons, Syndiotactic-polystryrene (SPS), Polybutylene Terephthalate (PBT), Polycarbonate (PC), Acrylonitrile Butadiene Styrene (ABS), Polyphthalamide (PPA), Polymide, Polyethylene Terephthalate (PET), Polyamide-imide (PAI), Acrylic (PMMA), Polystyrene (PS and HIPS), Polyether Sulfone (PES), Aliphatic Polyketone, Acetal (POM) Copolymer, Polyurethane (PU and TPU), Nylon with Polyphenylene-oxide dispersion and Acrylonitrile Styrene Acrylate.


As mentioned above, and with particular respect to tissue sealing, two mechanical factors play an important role in determining the resulting thickness of the sealed tissue and effectiveness of a tissue seal, i.e., the pressure applied between opposing jaw members 280 and 282 and the gap distance “G” between the opposing tissue contacting surfaces 284 and 286 during the sealing process. The gap distance “G” during sealing ranges from about 0.001 inches to about 0.006 inches and, preferably, between about 0.002 inches and about 0.003 inches. The clamping pressure between the opposing tissue contacting surfaces 284 and 286 is preferably between about 3 kg/cm2 to about 16 kg/cm2.


As best seen in the cross section view of FIG. 3, at least one of the electrically conductive tissue contacting surfaces 284 and 286 includes an energy conductive, ablative material 300 disposed thereon. With particular respect to vessel sealing, as shown in the illustrative example of FIG. 3, each electrically conductive tissue contacting surface 284 and 286 may include an ablative material 300 disposed thereon that is designed to burn off or deplete during electrical application. The burning off of ablative material 300 essentially keeps the tissue from sticking or adhering to the tissue contacting surfaces 284 and 286. More particularly, as electrosurgical energy is supplied to the tissue contacting surfaces 284 and 286 for treating tissue, the formulation of the ablative material 300 reacts to the electrical and/or thermal energy created by the electrosurgical activation and essentially burns off or steadily depletes, which prevents tissue from adhering to the tissue surfaces 284 and 286.


The ablative material 300 may be formulated or designed to essentially “burn off” or deplete during any type of energy application, e.g., ultrasonic, microwave, thermal and/or radiofrequency energy application, or based on a specific type of energy application, e.g., RF energy application, to reduce tissue adherence to the tissue contacting surfaces 284 and 286. For example, the ablative material 300 may be formulated or designed to burn off due to the heat build-up on the tissue contacting surfaces 284 and 286 or, in other instances, based on thermo-mechanical operating parameters (e.g., heat and vibration) and/or thermo-electrical operating parameters (microwave).


The ablative material may be formulated or formed from a combination of one or more of the following materials fiberglass material impregnated with phenolic resin and silica powder; combinations of phenolic resin, polyamide and silica powder; silicone elastomer, rayon-based carbon material, ceramic-forming polymer, or other ceramics, polymers, ceramic, metal, silica, phenol, fiberglass, etc.


In addition, the ablative material 300 may be manually applied to the tissue contacting surfaces prior to tissue treatment in the form of a liquid or gel or the ablative material may be added to the tissue contacting surfaces during a manufacturing step. In the latter instance, the material may be applied to the tissue surfaces initially as a liquid or gel material and allowed to harden prior to application. Additional ablative material 300 may be re-applied during use as needed when tissue sticking is apparent. Alternatively, the ablative material 300 may be a solid layer and applied during a manufacturing step or applied by a surgeon prior to electrical activation like tape or a boot over the tissue contacting surfaces 284 and 286.


In one embodiment, the ablative material is formulated or formed from a biocompatible substance. The ablative material 300 may also include one or more coagulants or antibodies or antibiotics, which may be absorbed by the tissue during treatment. In the case of complete burn off, these formulations may burn off into a gaseous state which is readily absorbed by the tissue to promote healing. In instances where the ablative material does not burn off into a gaseous state, but burns off into a liquid, semi-liquid (e.g., oozing) or solid state (e.g., “flake off”), the ablative material 300 is not harmful to tissue and may also be formulated or designed to promote healing.


With continued reference to FIG. 3, the electrode assembly 210 may also include one or more sensors 305 and 306 connected to respective tissue contacting surfaces 284 and 286 that are configured to monitor the burn off rate of the ablative material from the tissue contacting surfaces 284 and 286. More particularly, the sensors 305 and 306 monitor the rate at which the ablative material 300 is depleted or reduced in thickness or quality (e.g., the so-called “depletion rate” of the ablative material 300) and relay information relating to the depletion rate back to the generator 500. The generator 500 may be designed to include one or more algorithms that monitor at least one electrical property of the electrically conductive tissue surface(s) and continuously modify energy delivery based thereon.


The generator 500 may also be designed to include one or more algorithms that both monitor the depletion rate and continuously adjust the electrosurgical output of the generator 500 based thereon. The generator may include one or more audible and/or visual indicators 520 that warn a user when the sensor relays information relating to the depletion rate or overall depletion loss that falls within a predefined threshold. For example, the generator 500 may automatically shut off when the depletion rate or the overall depletion loss is likely to lead to tissue adherence. In another example, the generator measures the changes in electrical properties of the tissue surface corresponding to the amount of ablative material loss over time and modifies the electrosurgical energy delivery based thereon to maintain proper energy delivery during electrosurgery.


The ablative material 300 may be formulated or designed for a specific number of electrical activations for disposable electrosurgical instruments or the ablative material 300 may be formulated to withstand a specified number of sterilization cycles for reposable or reusable instruments.


In one envisioned embodiment, the ablative material 300 may be formulated to naturally burn off or deplete over time simply based on exposure to the atmosphere. In this instance, the ablative material may be applied to the tissue contacting surface or surfaces 284 and 286 and hermetically sealed during a manufacturing step or may be applied to the tissue contacting surfaces 284 and 286 just prior to electrical activation. In the latter instance, additional ablative material 300 may be re-applied during use as needed when tissue sticking is apparent. As can be appreciated, this would allow the surgeon to grasp and manipulate tissue without sticking and not require the surgeon to activate the instrument if there is tissue.


With particular reference to FIG. 2 and as mentioned above, one of the jaw members 280 may include an electrically conductive cutting element 295 that is selectively translatable within channel 294 defined in one or both the jaw members 280 and 286 to cut tissue prior to, simultaneously with or after tissue treatment. The cutting element 295 may be simply mechanical or may be electrically conductive. In the latter instance, the cutting element 295 may include the same ablative material 300 disposed thereon. The cutting element 295 may also include a different ablative material selected from the list identified above depending upon a specific purpose. As can be appreciated, by applying the ablative material to the cutting element 295, tissue adherence may be reduced during an electromechanical cutting phase of operation of the instrument. A suitable switch (not shown) may be employed to allow the surgeon to selectively activate tissue contacting surfaces 284 and 286 or the cutting element 295 independently of one another.


From the foregoing and with reference to the various figure drawings, those skilled in the art will appreciate that certain modifications can also be made to the present disclosure without departing from the scope of the present disclosure. For example, although an open instrument is described and shown having the ablative material 300 disposed thereon, it is envisioned that endoscopic electrosurgical instruments may be similarly configured to include the ablative material and the above-described appurtenances relating thereto (i.e., sensors, algorithms, etc.). Moreover, it is contemplated that other electrosurgical instruments may be configured to include the presently-disclosed ablative material 300, e.g., microwave instruments, ablation instruments, scissors, ultrasonic instruments, electrosurgical pencils, resistively heated instruments, knives and scalpels, etc.


The tissue contacting surfaces may also include one or more insulative stop members of any geometric configuration disposed on the inwardly-facing surfaces thereof (in any spatial layout or pattern), which are configured to regulate the gap distance to within the above-mentioned gap range of about 0.001 inches to about 0.006 inches.


The electrode assembly 110, 210 could be selectively detachable (i.e., reposable) from the shaft 12, 212, respectively, depending upon a particular purpose. Alternatively, the entire instrument could be disposable. For example, specific forceps 10, 200 may be configured for different tissue types or thicknesses. Moreover, a reusable forceps 10, 200 could be sold as a kit having different electrodes assemblies 110, 210 and ablative materials for different tissue types. The surgeon simply selects the appropriate electrode assembly and ablative material for a particular tissue type.


While several embodiments of the disclosure have been shown in the drawings, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Therefore, the above description should not be construed as limiting, but merely as exemplifications of preferred embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.

Claims
  • 1. An electrode assembly for use with an electrosurgical instrument, the electrode assembly comprising: a pair of opposing first and second jaw members being movable relative to one another from a first position wherein the jaw members are disposed in spaced relation relative to one another to a second position wherein the jaw members cooperate to grasp tissue therebetween;each jaw member including an electrically conductive tissue contacting surface, each of the tissue contacting surfaces adapted to connect to a source of electrosurgical energy such that the tissue contacting surfaces are capable of conducting electrosurgical energy through tissue held therebetween;at least one of the tissue contacting surfaces of one of the jaw members including an energy conductive, ablative material disposed thereon, the energy conductive, ablative material configured to at least partially deplete during electrosurgical activation to reduce tissue adhesion; anda sensor adapted to monitor a depletion rate of the energy conductive, ablative material and configured to relay information relating to the depletion rate to the source of electrosurgical energy.
  • 2. An electrode assembly according to claim 1 wherein the energy conductive, ablative material is applied to the at least one of the tissue contacting surfaces prior to electrosurgical application in the form of at least one of a gel and liquid material.
  • 3. An electrode assembly according to claim 1 wherein the energy conductive, ablative material is sterilizeable for a pre-determined number of sterilization cycles.
  • 4. An electrode assembly according to claim 1 wherein the energy conductive, ablative material is selected from the group consisting of fiberglass material impregnated with phenolic resin and silica powder, combinations of phenolic resin, polyamide and silica powder; silicone elastomer, rayon-based carbon material and ceramic-forming polymer.
  • 5. A system for sealing tissue, comprising: a pair of opposing first and second jaw members being movable relative to one another from a first position wherein the jaw members are disposed in spaced relation relative to one another to a second position wherein the jaw members cooperate to grasp tissue therebetween;each jaw member including an electrically conductive tissue contacting surface, at least one of the tissue contacting surfaces adapted to connect to a source of electrosurgical energy such that the tissue contacting surfaces are capable of conducting electrosurgical energy through tissue held therebetween to effect a tissue seal;at least one of the tissue contacting surfaces of one of the jaw members including an energy conductive, ablative material disposed thereon, the energy conductive, ablative material configured to at least partially burn off during electrosurgical activation to reduce tissue adhesion;a sensor adapted to monitor a depletion rate of the energy conductive, ablative material and configured to relay information relating to the depletion rate to the source of electrosurgical energy; andwherein at least one electrical property of the at least one electrically conductive surface is monitored to control energy delivery during electrosurgical activation.
  • 6. An electrode assembly according to claim 5 wherein the at least one electrical property of the electrically conductive surface includes at least one of impedance, current and voltage.
  • 7. An electrode assembly according to claim 5 wherein the energy conductive, ablative material is selected from the group consisting of fiberglass material impregnated with phenolic resin and silica powder, combinations of phenolic resin, polyamide and silica powder; silicone elastomer, rayon-based carbon material and ceramic-forming polymer.
  • 8. The system according to claim 5 further including a source of electrosurgical energy, the source of electrosurgical energy includes at least one of an audible and visual indicator configured to alert a user when the sensor relays information relating to the depletion rate that falls within a predefined threshold.
  • 9. The system according to claim 5 further including a source of electrosurgical energy, the source of electrosurgical energy configured to measure the changes in electrical properties of the at least one tissue contacting surface corresponding to the amount of energy conductive, ablative material depleted over time and modify the electrosurgical energy delivery based thereon to maintain proper energy delivery during electrosurgery.
  • 10. A system for sealing tissue, comprising: a pair of opposing first and second jaw members being movable relative to one another from a first position wherein the jaw members are disposed in spaced relation relative to one another to a second position wherein the jaw members cooperate to grasp tissue therebetween;each jaw member including an electrically conductive tissue contacting surface, each of the tissue contacting surfaces adapted to connect to a source of electrosurgical energy such that the tissue contacting surfaces are capable of conducting electrosurgical energy through tissue held therebetween;at least one of the tissue contacting surfaces of one of the jaw members including an energy conductive, ablative material disposed thereon, the energy conductive, ablative material being configured to at least partially deplete during electrosurgical activation to reduce tissue adhesion;a sensor adapted to connect to the electrosurgical energy source and configured to relay information relating to a depletion rate to the electrosurgical energy source; andan indicator configured to alert a user when the relayed information from the sensor relating to the depletion rate falls within a predefined threshold.
  • 11. A system for sealing tissue, comprising: a pair of opposing first and second jaw members being movable relative to one another from a first position wherein the jaw members are disposed in spaced relation relative to one another to a second position wherein the jaw members cooperate to grasp tissue therebetween;a source of electrosurgical energy;each jaw member including an electrically conductive tissue contacting surface, each of the tissue contacting surfaces connected to the source of electrosurgical energy such that the tissue contacting surfaces are capable of conducting electrosurgical energy through tissue held therebetween; andat least one of the tissue contacting surfaces of one of the jaw members including an energy conductive, ablative material disposed thereon, the energy conductive, ablative material configured to at least partially deplete during electrosurgical activation to reduce tissue adhesion, the energy conductive, ablative material is sterilizeable for a pre-determined number of sterilization cycles,wherein the source of electrosurgical energy measures the changes in electrical properties of the at least one electrically conductive surface corresponding to the amount of energy conductive, ablative material depleted over time and modifies the electrosurgical energy delivery based thereon to maintain proper energy delivery during electrosurgery.
  • 12. An electrode assembly according to claim 11 further comprising a sensor adapted to connect to the electrosurgical energy source and configured to relay information relating to a depletion rate to the source of electrosurgical energy.
US Referenced Citations (616)
Number Name Date Kind
371664 Brannan et al. Oct 1887 A
702472 Pignolet Jun 1902 A
728883 Downes May 1903 A
1586645 Bierman Jun 1926 A
1813902 Bovie Jul 1931 A
2002594 Wappler et al. May 1935 A
2011169 Wappler Aug 1935 A
2031682 Wappler et al. Feb 1936 A
2176479 Willis Oct 1939 A
2305156 Grubel Apr 1941 A
2279753 Knopp Apr 1942 A
2632661 Cristofv Aug 1948 A
2668538 Baker Feb 1954 A
2796065 Kapp Jun 1957 A
3459187 Pallotta Aug 1969 A
3643663 Sutter Feb 1972 A
3651811 Hildebrandt et al. Mar 1972 A
3720896 Beierlein Mar 1973 A
3862630 Balamuth Jan 1975 A
3863339 Reaney et al. Feb 1975 A
3866610 Kletschka Feb 1975 A
3911766 Fridolph et al. Oct 1975 A
3920021 Hiltebrandt Nov 1975 A
3921641 Hulka Nov 1975 A
3938527 Rioux et al. Feb 1976 A
3952749 Fridolph et al. Apr 1976 A
3970088 Morrison Jul 1976 A
3987795 Morrison Oct 1976 A
4005714 Hiltebrandt Feb 1977 A
4041952 Morrison, Jr. et al. Aug 1977 A
4043342 Morrison, Jr. Aug 1977 A
4074718 Morrison, Jr. Feb 1978 A
4088134 Mazzariello May 1978 A
4112950 Pike Sep 1978 A
4127222 Adams Nov 1978 A
4128099 Bauer Dec 1978 A
4165746 Burgin Aug 1979 A
4233734 Bies Nov 1980 A
4300564 Furihata Nov 1981 A
D263020 Rau, III Feb 1982 S
4370980 Lottick Feb 1983 A
4375218 DiGeronimo Mar 1983 A
4416276 Newton et al. Nov 1983 A
4418692 Guay Dec 1983 A
4452246 Bader et al. Jun 1984 A
4492231 Auth Jan 1985 A
4552143 Lottick Nov 1985 A
4574804 Kurwa Mar 1986 A
4597379 Kihn et al. Jul 1986 A
4600007 Lahodny et al. Jul 1986 A
4655215 Pike Apr 1987 A
4655216 Tischer Apr 1987 A
4657016 Garito et al. Apr 1987 A
4662372 Sharkany et al. May 1987 A
4671274 Sorochenko Jun 1987 A
4685459 Xoch et al. Aug 1987 A
D295893 Sharkany et al. May 1988 S
D295894 Sharkany et al. May 1988 S
4754892 Retief Jul 1988 A
4763669 Jaeger Aug 1988 A
4827929 Hodge May 1989 A
4846171 Kauphusman et al. Jul 1989 A
4887612 Esser et al. Dec 1989 A
4938761 Ensslin Jul 1990 A
4985030 Melzer et al. Jan 1991 A
5007908 Rydell Apr 1991 A
5026370 Lottick Jun 1991 A
5035695 Weber, Jr. et al. Jul 1991 A
5084057 Green et al. Jan 1992 A
5099840 Goble et al. Mar 1992 A
5116332 Lottick May 1992 A
5147357 Rose et al. Sep 1992 A
5151102 Xamiyama et al. Sep 1992 A
5176695 Dulebohn Jan 1993 A
5190541 Abele et al. Mar 1993 A
5196009 Kirwan, Jr. Mar 1993 A
5197964 Parins Mar 1993 A
5215101 Jacobs et al. Jun 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217458 Parins Jun 1993 A
5217460 Knoepfler Jun 1993 A
5219354 Choudhury et al. Jun 1993 A
5244462 Delahuerga et al. Sep 1993 A
5250047 Rydell Oct 1993 A
5250063 Abidin et al. Oct 1993 A
5258001 Corman Nov 1993 A
5258006 Rydell et al. Nov 1993 A
5261918 Phillips et al. Nov 1993 A
5275615 Rose Jan 1994 A
5277201 Stern Jan 1994 A
5282799 Rydell Feb 1994 A
5290286 Parins Mar 1994 A
5304203 El-Mallawany et al. Apr 1994 A
5308357 Lichtman May 1994 A
5314445 Degwitz et al. May 1994 A
5318589 Lichtman Jun 1994 A
5324289 Eggers Jun 1994 A
5326806 Yokoshima et al. Jul 1994 A
5330471 Eggers Jul 1994 A
5334183 Wuchinich Aug 1994 A
5334215 Chen Aug 1994 A
5336220 Ryan et al. Aug 1994 A
5336221 Anderson Aug 1994 A
5342359 Rydell Aug 1994 A
5342381 Tidemand Aug 1994 A
5342393 Stack Aug 1994 A
5344424 Roberts et al. Sep 1994 A
5352222 Rydell Oct 1994 A
5354271 Voda Oct 1994 A
5356408 Rydell Oct 1994 A
5366477 LeMarie, III et al. Nov 1994 A
5368600 Failla et al. Nov 1994 A
5376089 Smith Dec 1994 A
5383897 Wholey Jan 1995 A
5389098 Tsuruta et al. Feb 1995 A
5389104 Hahnen et al. Feb 1995 A
5391166 Eggers Feb 1995 A
5391183 Janzen et al. Feb 1995 A
5396900 Slater et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5411519 Tovey et al. May 1995 A
5411520 Nash et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5415657 Taymor-Luria May 1995 A
5422567 Matsunaga Jun 1995 A
5423810 Goble et al. Jun 1995 A
5425690 Chang Jun 1995 A
5425739 Jessen Jun 1995 A
5429616 Schaffer Jul 1995 A
5431672 Cote et al. Jul 1995 A
5431674 Basile et al. Jul 1995 A
5437292 Kipshidze et al. Aug 1995 A
5438302 Goble Aug 1995 A
5441517 Kensey et al. Aug 1995 A
5443463 Stern et al. Aug 1995 A
5443464 Russell et al. Aug 1995 A
5443480 Jacobs et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5445658 Durrfeld et al. Aug 1995 A
5451224 Goble et al. Sep 1995 A
5456684 Schmidt et al. Oct 1995 A
5458598 Feinberg et al. Oct 1995 A
5460629 Shlain et al. Oct 1995 A
5462546 Rydell Oct 1995 A
5472443 Cordis et al. Dec 1995 A
5478351 Meade et al. Dec 1995 A
5480409 Riza Jan 1996 A
5484436 Eggers et al. Jan 1996 A
5496312 Klicek Mar 1996 A
5496317 Goble et al. Mar 1996 A
5496347 Hashiguchi et al. Mar 1996 A
5499997 Sharpe et al. Mar 1996 A
5509922 Aranyi et al. Apr 1996 A
5514134 Rydell et al. May 1996 A
5527313 Scott et al. Jun 1996 A
5531744 Nardella et al. Jul 1996 A
5536251 Evard et al. Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5540685 Parins et al. Jul 1996 A
5540715 Katsaros et al. Jul 1996 A
5542945 Fritzsch Aug 1996 A
5549604 Sutcu et al. Aug 1996 A
5558671 Yates Sep 1996 A
5558672 Edwards et al. Sep 1996 A
5562699 Heimberger et al. Oct 1996 A
5569241 Edwardds Oct 1996 A
5569243 Kortenbach et al. Oct 1996 A
5571100 Goble et al. Nov 1996 A
5573424 Poppe Nov 1996 A
5573534 Stone Nov 1996 A
5573535 Viklund Nov 1996 A
5575805 Li Nov 1996 A
5578052 Koros et al. Nov 1996 A
5582611 Tsuruta et al. Dec 1996 A
5585896 Yamazaki et al. Dec 1996 A
5590570 LeMaire, III et al. Jan 1997 A
5601601 Tal et al. Feb 1997 A
5603711 Parins et al. Feb 1997 A
5603723 Aranyi et al. Feb 1997 A
5611798 Eggers Mar 1997 A
5620453 Nallakrishnan Apr 1997 A
5624452 Yates Apr 1997 A
5626578 Tihon May 1997 A
5626609 Zvenyatsky et al. May 1997 A
5630833 Katsaros et al. May 1997 A
5637110 Pennybacker et al. Jun 1997 A
5638003 Hall Jun 1997 A
5643294 Tovey et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5647871 Levine et al. Jul 1997 A
5649959 Hannam et al. Jul 1997 A
5658281 Heard Aug 1997 A
5662667 Knodel Sep 1997 A
5665100 Yoon Sep 1997 A
5667526 Levin Sep 1997 A
5674220 Fox et al. Oct 1997 A
5681282 Eggers et al. Oct 1997 A
5688270 Yates et al. Nov 1997 A
5693051 Schulze et al. Dec 1997 A
5695522 LeMaire, III et al. Dec 1997 A
5700261 Brinkerhoff Dec 1997 A
5702390 Austin et al. Dec 1997 A
5707369 Vaitekunas et al. Jan 1998 A
5709680 Yates et al. Jan 1998 A
5716366 Yates Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
5722421 Francese et al. Mar 1998 A
5725536 Oberlin et al. Mar 1998 A
5727428 LeMaire, III et al. Mar 1998 A
5735848 Yates et al. Apr 1998 A
5743906 Parins et al. Apr 1998 A
5755717 Yates et al. May 1998 A
5766130 Selmonosky Jun 1998 A
5766166 Hooven Jun 1998 A
5766170 Eggers Jun 1998 A
5769849 Eggers Jun 1998 A
5772655 Bauer et al. Jun 1998 A
5772670 Brosa Jun 1998 A
5776128 Eggers Jul 1998 A
5776130 Buysse et al. Jul 1998 A
5779701 McBrayer et al. Jul 1998 A
H1745 Paraschac Aug 1998 H
5792137 Carr et al. Aug 1998 A
5792177 Kaseda Aug 1998 A
5797927 Yoon Aug 1998 A
5797938 Paraschac et al. Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5797958 Yoon Aug 1998 A
5800449 Wales Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5807394 Sakai et al. Sep 1998 A
5810808 Eggers Sep 1998 A
5810811 Yates et al. Sep 1998 A
5810877 Roth et al. Sep 1998 A
5814043 Shapeton Sep 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5820630 Lind Oct 1998 A
5827271 Buysse et al. Oct 1998 A
5827279 Hughett et al. Oct 1998 A
5827281 Levin Oct 1998 A
5827323 Klieman et al. Oct 1998 A
5827548 Lavallee et al. Oct 1998 A
5833690 Yates et al. Nov 1998 A
5843080 Fleenor et al. Dec 1998 A
5849022 Sakashita et al. Dec 1998 A
5853412 Mayenberger Dec 1998 A
5860976 Billings et al. Jan 1999 A
5876401 Schulze et al. Mar 1999 A
5882567 Cavallaro et al. Mar 1999 A
5891141 Rydell Apr 1999 A
5891142 Eggers et al. Apr 1999 A
5893863 Yoon Apr 1999 A
5893875 O'Connor et al. Apr 1999 A
5893877 Gampp, Jr. et al. Apr 1999 A
5902301 Olig May 1999 A
5906630 Anderhub et al. May 1999 A
5908420 Parins et al. Jun 1999 A
5908432 Pan Jun 1999 A
5911719 Eggers Jun 1999 A
5913874 Berns et al. Jun 1999 A
5921984 Sutcu et al. Jul 1999 A
5925043 Kumar et al. Jul 1999 A
5935126 Riza Aug 1999 A
5944718 Austin et al. Aug 1999 A
5951549 Richardson et al. Sep 1999 A
5954720 Wilson et al. Sep 1999 A
5957923 Hahnen et al. Sep 1999 A
5960544 Beyers Oct 1999 A
5961514 Long et al. Oct 1999 A
5964758 Dresden Oct 1999 A
5976132 Morris Nov 1999 A
5984939 Yoon Nov 1999 A
5989277 LeMaire, III et al. Nov 1999 A
5997565 Inoue Dec 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6010516 Hulka et al. Jan 2000 A
6024741 Williamson et al. Feb 2000 A
6024744 Kese et al. Feb 2000 A
6030384 Nezhat Feb 2000 A
6033399 Gines Mar 2000 A
6039733 Buysse et al. Mar 2000 A
6041679 Slater et al. Mar 2000 A
6050996 Schmaltz et al. Apr 2000 A
6053914 Eggers et al. Apr 2000 A
6053933 Balazs et al. Apr 2000 A
D424694 Tetzlaff et al. May 2000 S
D425201 Tetzlaff et al. May 2000 S
6059782 Novak et al. May 2000 A
6074386 Goble et al. Jun 2000 A
RE36795 Rydell Jul 2000 E
6083223 Baker Jul 2000 A
6086586 Hooven Jul 2000 A
6090107 Borgmeier et al. Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6099550 Yoon Aug 2000 A
6102909 Chen et al. Aug 2000 A
6110171 Rydell Aug 2000 A
6113596 Hooven et al. Sep 2000 A
6113598 Baker Sep 2000 A
6117158 Measamer et al. Sep 2000 A
6123701 Nezhat Sep 2000 A
H1904 Yates et al. Oct 2000 H
6126658 Baker Oct 2000 A
6152923 Ryan Nov 2000 A
6162220 Nezhat Dec 2000 A
6174309 Wrublewski et al. Jan 2001 B1
6179834 Buysse et al. Jan 2001 B1
6179837 Hooven Jan 2001 B1
6183467 Shapeton et al. Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6190386 Rydell Feb 2001 B1
6193718 Kortenbach et al. Feb 2001 B1
6206876 Levine et al. Mar 2001 B1
6206877 Kese et al. Mar 2001 B1
6217602 Redmon Apr 2001 B1
6221039 Durgin et al. Apr 2001 B1
6224593 Ryan et al. May 2001 B1
6228080 Gines May 2001 B1
6228083 Lands et al. May 2001 B1
6267761 Ryan Jul 2001 B1
6270497 Sekino et al. Aug 2001 B1
6270508 Klieman et al. Aug 2001 B1
6273887 Yamauchi et al. Aug 2001 B1
6277117 Tetzlaff et al. Aug 2001 B1
6280458 Boche et al. Aug 2001 B1
6283961 Underwood et al. Sep 2001 B1
D449886 Tetzlaff et al. Oct 2001 S
6302424 Gisinger et al. Oct 2001 B1
6319451 Brune Nov 2001 B1
6322561 Eggers et al. Nov 2001 B1
6334860 Dorn Jan 2002 B1
6334861 Chandler et al. Jan 2002 B1
6345532 Coudray et al. Feb 2002 B1
6350264 Hooven Feb 2002 B1
6352536 Buysse et al. Mar 2002 B1
6358249 Chen et al. Mar 2002 B1
6358268 Hunt et al. Mar 2002 B1
D457958 Dycus et al. May 2002 S
D457959 Tetzlaff et al. May 2002 S
6387094 Eitenmuller May 2002 B1
6391035 Appleby et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6402747 Lindemann et al. Jun 2002 B1
6409725 Khandkar et al. Jun 2002 B1
6409728 Ehr et al. Jun 2002 B1
H2037 Yates et al. Jul 2002 H
6419675 Gallo, Sr. Jul 2002 B1
6425896 Baltschun et al. Jul 2002 B1
6440144 Bacher Aug 2002 B1
6443952 Mulier et al. Sep 2002 B1
6443970 Schulze et al. Sep 2002 B1
6451018 Lands et al. Sep 2002 B1
6458125 Cosmescu Oct 2002 B1
6458128 Schulze Oct 2002 B1
6458130 Frazier et al. Oct 2002 B1
6464701 Hooven et al. Oct 2002 B1
6464702 Schulze et al. Oct 2002 B2
6464704 Schmaltz et al. Oct 2002 B2
6500176 Truckai et al. Dec 2002 B1
6511480 Tetzlaff et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6527771 Weadock et al. Mar 2003 B1
6558385 McClurken et al. May 2003 B1
6562037 Paton et al. May 2003 B2
6585735 Frazier et al. Jul 2003 B1
6602252 Mollenauer Aug 2003 B2
6616658 Ineson Sep 2003 B2
6616661 Wellman et al. Sep 2003 B2
6620161 Schulze et al. Sep 2003 B2
6626901 Treat et al. Sep 2003 B1
6641595 Moran et al. Nov 2003 B1
6652514 Ellman et al. Nov 2003 B2
6652521 Schulze Nov 2003 B2
6656177 Truckai et al. Dec 2003 B2
6660072 Chatterjee Dec 2003 B2
6669696 Bacher et al. Dec 2003 B2
6676660 Wampler et al. Jan 2004 B2
6679882 Kornerup Jan 2004 B1
6682527 Strul Jan 2004 B2
6682528 Frazier et al. Jan 2004 B2
6685724 Haluck Feb 2004 B1
6689131 McClurken Feb 2004 B2
6692445 Roberts et al. Feb 2004 B2
6695840 Schulze Feb 2004 B2
6702810 McClurken et al. Mar 2004 B2
6726068 Miller Apr 2004 B2
6726686 Buysse et al. Apr 2004 B2
6733498 Paton et al. May 2004 B2
6736813 Yamauchi et al. May 2004 B2
6743229 Buysse et al. Jun 2004 B2
6743230 Lutze et al. Jun 2004 B2
6757977 Dambal et al. Jul 2004 B2
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773434 Ciarrocca Aug 2004 B2
6775575 Bommannan et al. Aug 2004 B2
6776780 Mulier et al. Aug 2004 B2
6786905 Swanson et al. Sep 2004 B2
6790217 Schulze et al. Sep 2004 B2
6796981 Wham et al. Sep 2004 B2
D496997 Dycus et al. Oct 2004 S
6802843 Truckai et al. Oct 2004 B2
6808525 Latterell et al. Oct 2004 B2
D499181 Dycus et al. Nov 2004 S
6818000 Muller et al. Nov 2004 B2
6860880 Treat et al. Mar 2005 B2
6887240 Lands et al. May 2005 B1
6926716 Baker et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6932810 Ryan Aug 2005 B2
6932816 Phan Aug 2005 B2
6934134 Mori et al. Aug 2005 B2
6936061 Sasaki Aug 2005 B2
6942662 Goble et al. Sep 2005 B2
6951559 Greep Oct 2005 B1
6953461 McClurken et al. Oct 2005 B2
6958070 Witt et al. Oct 2005 B2
6960210 Lands et al. Nov 2005 B2
6964662 Kidooka Nov 2005 B2
6966907 Goble Nov 2005 B2
6977495 Donofrio Dec 2005 B2
6979786 Aukland et al. Dec 2005 B2
6994707 Ellman et al. Feb 2006 B2
6994709 Iida Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7033354 Keppel Apr 2006 B2
7033356 Latterell et al. Apr 2006 B2
7041102 Truckai et al. May 2006 B2
7044948 Keppel May 2006 B2
7052496 Yamauchi May 2006 B2
D525361 Hushka Jul 2006 S
7070597 Truckai et al. Jul 2006 B2
7083618 Couture et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7090689 Nagase et al. Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7103947 Sartor et al. Sep 2006 B2
7112199 Cosmescu Sep 2006 B2
D531311 Guerra et al. Oct 2006 S
7115123 Knowlton et al. Oct 2006 B2
7118570 Tetzlaff et al. Oct 2006 B2
7118587 Dycus et al. Oct 2006 B2
7131860 Sartor et al. Nov 2006 B2
7131970 Moses et al. Nov 2006 B2
7131971 Dycus et al. Nov 2006 B2
7135020 Lawes et al. Nov 2006 B2
D533942 Kerr et al. Dec 2006 S
7145757 Shea et al. Dec 2006 B2
7147638 Chapman et al. Dec 2006 B2
7150097 Sremcich et al. Dec 2006 B2
7150749 Dycus et al. Dec 2006 B2
D535027 James et al. Jan 2007 S
7156842 Sartor et al. Jan 2007 B2
7156846 Dycus et al. Jan 2007 B2
7160298 Lawes et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7179258 Buysse et al. Feb 2007 B2
7195631 Dumbauld Mar 2007 B2
D541418 Schechter et al. Apr 2007 S
7207990 Lands et al. Apr 2007 B2
D541938 Kerr et al May 2007 S
7223265 Keppel May 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7241288 Braun Jul 2007 B2
7241296 Buysse et al. Jul 2007 B2
7252667 Moses et al. Aug 2007 B2
7255697 Dycus et al. Aug 2007 B2
7267677 Johnson et al. Sep 2007 B2
7270660 Ryan Sep 2007 B2
7270664 Johnson et al. Sep 2007 B2
7276068 Johnson et al. Oct 2007 B2
7300435 Wham et al. Nov 2007 B2
7303557 Wham et al. Dec 2007 B2
7314471 Holman Jan 2008 B2
7329256 Johnson et al. Feb 2008 B2
7329257 Kanehira et al. Feb 2008 B2
D564662 Moses et al. Mar 2008 S
7342754 Fitzgerald et al. Mar 2008 B2
7344268 Jigamian Mar 2008 B2
7367976 Lawes et al. May 2008 B2
20020013583 Camran et al. Jan 2002 A1
20020049442 Roberts et al. Apr 2002 A1
20020099372 Schulze et al. Jul 2002 A1
20020107517 Witt et al. Aug 2002 A1
20020111624 Witt et al. Aug 2002 A1
20020188294 Couture et al. Dec 2002 A1
20030014052 Buysse et al. Jan 2003 A1
20030014053 Nguyen et al. Jan 2003 A1
20030018331 Dycus et al. Jan 2003 A1
20030018332 Schmaltz et al. Jan 2003 A1
20030032956 Lands et al. Feb 2003 A1
20030069571 Treat et al. Apr 2003 A1
20030078578 Truckai et al. Apr 2003 A1
20030109875 Tetzlaff et al. Jun 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030139742 Wampler et al. Jul 2003 A1
20030158549 Swanson Aug 2003 A1
20030181910 Dycus et al. Sep 2003 A1
20030195513 Truckai et al. Oct 2003 A1
20030199869 Johnson et al. Oct 2003 A1
20030216732 Truckai et al. Nov 2003 A1
20030220637 Truckai et al. Nov 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20030236325 Bonora Dec 2003 A1
20040030330 Brassell et al. Feb 2004 A1
20040030332 Knowlton et al. Feb 2004 A1
20040049185 Latterell et al. Mar 2004 A1
20040064151 Mollenauer Apr 2004 A1
20040078035 Kanehira et al. Apr 2004 A1
20040082952 Dycus et al. Apr 2004 A1
20040087943 Dycus et al. May 2004 A1
20040115296 Duffin Jun 2004 A1
20040116924 Dycus et al. Jun 2004 A1
20040116979 Truckai et al. Jun 2004 A1
20040122423 Dycus et al. Jun 2004 A1
20040143263 Schechter et al. Jul 2004 A1
20040147925 Buysse et al. Jul 2004 A1
20040162557 Tetzlaff et al. Aug 2004 A1
20040193153 Sarter et al. Sep 2004 A1
20040230189 Keppel Nov 2004 A1
20040236326 Schulze et al. Nov 2004 A1
20040243125 Dycus et al. Dec 2004 A1
20040249371 Dycus et al. Dec 2004 A1
20040249374 Tetzlaff et al. Dec 2004 A1
20040260281 Baxter, III et al. Dec 2004 A1
20050004564 Wham et al. Jan 2005 A1
20050021025 Buysse et al. Jan 2005 A1
20050021027 Shields et al. Jan 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050055021 Clement et al. Mar 2005 A1
20050096645 Wellman et al. May 2005 A1
20050101951 Wham et al. May 2005 A1
20050101952 Lands et al. May 2005 A1
20050107784 Moses et al. May 2005 A1
20050113818 Sartor et al. May 2005 A1
20050113819 Wham et al. May 2005 A1
20050113826 Johnson et al. May 2005 A1
20050113827 Dumbauld et al. May 2005 A1
20050113828 Shields et al. May 2005 A1
20050149017 Dycus Jul 2005 A1
20050149151 Orszulak et al. Jul 2005 A1
20050154385 Heim et al. Jul 2005 A1
20050187547 Sugi Aug 2005 A1
20050197659 Bahney Sep 2005 A1
20050203504 Wham et al. Sep 2005 A1
20050240179 Buysse et al. Oct 2005 A1
20060052778 Chapman et al. Mar 2006 A1
20060064085 Schechter et al. Mar 2006 A1
20060074417 Cunningham et al. Apr 2006 A1
20060079888 Mulier et al. Apr 2006 A1
20060079890 Guerra Apr 2006 A1
20060079891 Arts et al. Apr 2006 A1
20060116675 McClurken et al. Jun 2006 A1
20060129146 Dycus et al. Jun 2006 A1
20060161150 Keppel Jul 2006 A1
20060167450 Johnson et al. Jul 2006 A1
20060167452 Moses et al. Jul 2006 A1
20060173452 Buysse et al. Aug 2006 A1
20060189980 Johnson et al. Aug 2006 A1
20060190035 Hushka et al. Aug 2006 A1
20060217709 Couture et al. Sep 2006 A1
20060224158 Odom et al. Oct 2006 A1
20060259036 Tetzlaff et al. Nov 2006 A1
20060264922 Sartor et al. Nov 2006 A1
20060264931 Chapman et al. Nov 2006 A1
20060271038 Johnson et al. Nov 2006 A1
20060287641 Perlin Dec 2006 A1
20070016182 Lipson et al. Jan 2007 A1
20070016187 Weinberg et al. Jan 2007 A1
20070043352 Garrison et al. Feb 2007 A1
20070043353 Dycus et al. Feb 2007 A1
20070055231 Dycus et al. Mar 2007 A1
20070060919 Isaacson et al. Mar 2007 A1
20070062017 Dycus et al. Mar 2007 A1
20070074807 Guerra Apr 2007 A1
20070078456 Dumbauld et al. Apr 2007 A1
20070078458 Dumbauld et al. Apr 2007 A1
20070078459 Johnson et al. Apr 2007 A1
20070088356 Moses et al. Apr 2007 A1
20070106295 Garrison et al. May 2007 A1
20070106297 Dumbauld et al. May 2007 A1
20070118111 Weinberg May 2007 A1
20070118115 Artale et al. May 2007 A1
20070142833 Dycus et al. Jun 2007 A1
20070142834 Dumbauld Jun 2007 A1
20070156139 Schechter et al. Jul 2007 A1
20070156140 Baily Jul 2007 A1
20070173811 Couture et al. Jul 2007 A1
20070173814 Hixson et al. Jul 2007 A1
20070179499 Garrison Aug 2007 A1
20070203485 Keppel Aug 2007 A1
20070213706 Dumbauld et al. Sep 2007 A1
20070213707 Dumbauld et al. Sep 2007 A1
20070213708 Dumbauld et al. Sep 2007 A1
20070213712 Buysse et al. Sep 2007 A1
20070255279 Buysse et al. Nov 2007 A1
20070260235 Podhajsky Nov 2007 A1
20070260238 Guerra Nov 2007 A1
20070260241 Dalla Betta et al. Nov 2007 A1
20070260242 Dycus et al. Nov 2007 A1
20070265616 Couture et al. Nov 2007 A1
20080004616 Patrick Jan 2008 A1
20080009860 Odom Jan 2008 A1
20080015575 Odom et al. Jan 2008 A1
20080021450 Couture Jan 2008 A1
20080033428 Artale et al. Feb 2008 A1
20080039835 Johnson et al. Feb 2008 A1
20080045947 Johnson et al. Feb 2008 A1
20080058802 Couture et al. Mar 2008 A1
20080082100 Orton et al. Apr 2008 A1
Foreign Referenced Citations (130)
Number Date Country
2104423 Feb 1994 CA
2415263 Oct 1975 DE
2627679 Jan 1977 DE
8712328 Mar 1988 DE
4303882 Aug 1994 DE
29616210 Jan 1997 DE
19608716 Apr 1997 DE
19751106 May 1998 DE
19751108 May 1999 DE
0364216 Apr 1990 EP
518230 Dec 1992 EP
0 541 930 May 1993 EP
0572131 Dec 1993 EP
584787 Mar 1994 EP
0589453 Mar 1994 EP
0623316 Nov 1994 EP
0624348 Nov 1994 EP
0650701 May 1995 EP
0694290 Mar 1996 EP
0717966 Jun 1996 EP
0754437 Mar 1997 EP
853922 Jul 1998 EP
0875209 Nov 1998 EP
0878169 Nov 1998 EP
0887046 Jan 1999 EP
0923907 Jun 1999 EP
0986990 Mar 2000 EP
1034747 Sep 2000 EP
1034748 Sep 2000 EP
1025807 Oct 2000 EP
1034746 Oct 2000 EP
1050278 Nov 2000 EP
1053719 Nov 2000 EP
1053720 Nov 2000 EP
1055399 Nov 2000 EP
1055400 Nov 2000 EP
1080694 Mar 2001 EP
1082944 Mar 2001 EP
1159926 Dec 2001 EP
1301135 Apr 2003 EP
1330991 Jul 2003 EP
1486177 Jun 2004 EP
1472984 Nov 2004 EP
1527747 May 2005 EP
1530952 May 2005 EP
1532932 May 2005 EP
1535581 Jun 2005 EP
1609430 Dec 2005 EP
1632192 Mar 2006 EP
1645238 Apr 2006 EP
1645240 Apr 2006 EP
1707143 Oct 2006 EP
2214430 Jun 1989 GB
2213416 Aug 1989 GB
501068 Sep 1984 JP
502328 Mar 1992 JP
5-5106 Jan 1993 JP
5-40112 Feb 1993 JP
06343644 Dec 1994 JP
07265328 Oct 1995 JP
08056955 Mar 1996 JP
08252263 Oct 1996 JP
09010223 Jan 1997 JP
11244298 Sep 1999 JP
2000342599 Dec 2000 JP
2000350732 Dec 2000 JP
2001008944 Jan 2001 JP
2001029356 Feb 2001 JP
2001128990 May 2001 JP
401367 Nov 1974 SU
WO 8900757 Jan 1989 WO
WO 9204873 Apr 1992 WO
WO 9206642 Apr 1992 WO
WO 9408524 Apr 1994 WO
WO 9420025 Sep 1994 WO
WO 9502369 Jan 1995 WO
WO 9507662 Mar 1995 WO
WO 9515124 Jun 1995 WO
WO 9605776 Feb 1996 WO
WO 9622056 Jul 1996 WO
WO 9613218 Sep 1996 WO
WO 9700646 Jan 1997 WO
WO 9700647 Jan 1997 WO
WO 9710764 Mar 1997 WO
WO 9724073 Jul 1997 WO
WO 9724993 Jul 1997 WO
WO 9827880 Jul 1998 WO
WO 9903407 Jan 1999 WO
WO 9903408 Jan 1999 WO
WO 9903409 Jan 1999 WO
WO 9912488 Mar 1999 WO
WO 9940857 Aug 1999 WO
WO 9940861 Aug 1999 WO
WO 9951158 Oct 1999 WO
WO 9966850 Dec 1999 WO
WO 0024330 May 2000 WO
WO 0024331 May 2000 WO
WO 0041638 Jul 2000 WO
WO 0047124 Aug 2000 WO
WO 0053112 Sep 2000 WO
WO 0117448 Mar 2001 WO
WO 0154604 Aug 2001 WO
WO 0207627 Jan 2002 WO
WO 02067798 Sep 2002 WO
WO 02080783 Oct 2002 WO
WO 02080784 Oct 2002 WO
WO 02080785 Oct 2002 WO
WO 02080786 Oct 2002 WO
WO 02080793 Oct 2002 WO
WO 02080794 Oct 2002 WO
WO 02080795 Oct 2002 WO
WO 02080796 Oct 2002 WO
WO 02080797 Oct 2002 WO
WO 02080798 Oct 2002 WO
WO 02080799 Oct 2002 WO
WO 02081170 Oct 2002 WO
WO 03090630 Nov 2003 WO
WO 03101311 Dec 2003 WO
WO 2004032776 Apr 2004 WO
WO 2004032777 Apr 2004 WO
WO 2004052221 Jun 2004 WO
WO 2004073488 Sep 2004 WO
WO 2004073490 Sep 2004 WO
WO 2004073753 Sep 2004 WO
WO 2004082495 Sep 2004 WO
WO 2004098383 Nov 2004 WO
WO 2004103156 Dec 2004 WO
WO 2005004734 Jan 2005 WO
WO 2005004735 Jan 2005 WO
WO 2005110264 Nov 2005 WO
Related Publications (1)
Number Date Country
20080091189 A1 Apr 2008 US